318 / 1084
Conclusions
•
Incidence of esophageal cancer is increasing
•
Prognosis is poor due to advanced stages at diagnosis
•
Treatment is challenging and requires multidisciplinary
approach
•
Largest gain is obtained in neo-adjuvant setting
(CRT>CT?)
•
Whether there is room for RT dose escalation remains
unanswered (subgroups? Better/safer RT techniques?)